CRANBURY, N.J.--(BUSINESS WIRE)--April 27, 2006--Valera Pharmaceuticals (NASDAQ:VLRX - News), a specialty pharmaceutical company focused on the development, acquisition and commercialization of products for the urology and endocrinology markets, today announced financial results for the first quarter ended March 31, 2006 and also reported milestone achievements.
